ERIDE QUARTA

Has grant

Assistant Professor,PhD

University Name

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Drug Delivery Drug Delivery professors in Italy

Contact this professor

ORCID

Google Scholar

About

Dr. Eride Quarta is an Assistant Professor at Università degli Studi di Parma, Dipartimento di Scienze degli Alimenti e del Farmaco, Italy. His research focuses on inhalation therapies, particularly in the context of respiratory diseases such as cystic fibrosis and COVID-19. Recent articles of Dr. Quarta explore topics including microparticle inhalation, polyelectrolyte complex formulations, and the role of airways microbiota in health.

Recent Grants

Grant: Close

H2020-NMBP-2016-2017

Open Date:

Close Date:

ERIDE QUARTA

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms

Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections

The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract

Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis

Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure

Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro

The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler

Nasal delivery as a strategy for the prevention and treatment of COVID-19

No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs

Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances

Recent Patents on Nasal Vaccines Containing Nanoadjuvants

Understanding the Importance of Capsules in Dry Powder Inhalers

Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design

Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen

Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer

Collaborators (13)

Francesca Buttini

Gaia Colombo

Fabio Sonvico

Leif-Hendrik Boldt

Regina Scherließ

Ruggero Bettini

benedetta bottari

VITTORIO SAMBRI

Jessica Modica

Simona Bertoni

Federico Lavorini

Annalisa BIANCHERA

Peter Deissler

How do I reach out?

Meet Kite AI